Last reviewed · How we verify

NCT06846632

Graftless Technique in Open Maxillary Sinus Lifting Using PEEK Versus Ti -Meshwork

Completed NA Last updated 26 February 2025
What this trial tests

NA trial testing PEEK in Maxillary Sinus in 12 participants. Completed in 3 November 2024.

Timeline
3 May 2024
Primary endpoint
3 October 2024
3 November 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment12
Start date3 May 2024
Primary completion3 October 2024
Estimated completion3 November 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 50, any sex, with Maxillary Sinus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the amount of bone formation with PEEK (intervention group) in comparison with Titanium Meshwork (control group) in maxillary sinus lifting using CBCT and assessment of the biocompatibility of the Meshwork and PEEK with the schniederian membrane integrity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of PEEK

Trials testing the same drug.

Other recruiting trials for Maxillary Sinus

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06846632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing